Shares of Pharmasset (VRUS) are up 4.1% premarket after the company announced positive results...


Shares of Pharmasset (VRUS) are up 4.1% premarket after the company announced positive results from a detailed test of its HCV treatment.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs